Hudson Bay Capital Management LP Geo Vax Labs, Inc. Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$39.45 - $85.95 $3.16 Million - $6.88 Million
-80,000 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$42.0 - $414.75 $3.36 Million - $33.2 Million
80,000 New
80,000 $255,000

About GeoVax Labs, Inc.

GOVX Quotes by TradingView
  • Ticker GOVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,744,000
  • Market Cap $55.9M
  • Description
  • GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...
More about GOVX
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email